GPC3 and hepatocellular carcinoma: A previous study demonstrated that inhibition of the GPC3 expression of HCC cells through RNA interference reduced the tumorigenicity in nude mice, which indicated that GPC3 may be a potential molecular target in HCC therapy (28).